Chen Ling, Zhu Youzhi, Zheng Ke, Zhang Huihao, Guo Hongkun, Zhang Li, Wu Kunlin, Kong Lingjun, Ruan Weihong, Hu Jianying, Zhang Xin, Chen Xiangjin
Department of Thyroid and Breast Surgery, The First Affiliated Hospital of FuJian Medical University, No. 20, Chazhong Road, ChaTing Street, FuZhou City, 350000, FuJian Province, China.
Department of Pathology, The First Affiliated Hospital of FuJian Medical University, No. 20, Chazhong Road, ChaTing Street, FuZhou City, 350000, Fujian Province, China.
J Cancer Res Clin Oncol. 2017 Jun;143(6):1035-1042. doi: 10.1007/s00432-017-2345-2. Epub 2017 Feb 15.
Several characteristics of lymph node metastasis (LNM) as predictors of the risk of recurrence or death were examined in patients with papillary thyroid carcinoma (PTC). The presence of cancerous nodules as a characteristic of LNMs in PTC has not yet been reported. The objective of this study was to evaluate the use of the cancerous nodules in the lymph node (CNLN) to determine the risk of distant metastasis and survival in patients with PTC.
This retrospective observational cohort study enrolled 1408 patients with pathologically confirmed PTC without initial distant metastasis who underwent thyroidectomy and neck dissection. All patients were divided into two groups (CNLN group and Non-CNLN group) according to the presence of CNLN.
Multivariate analyses showed that the presence of a special histologic variant (OR 3.31), CNLN (OR 7.13), and lateral LNM (OR 4.02) was an independent factor predictive of distant metastasis. Distant metastasis was found in 23.1% and 2.3% of patients in the CNLN and Non-CNLN group, respectively (p < 0.001). Furthermore, tumor-specific death was found in 7.7% and 0.6% of patients in the CNLN and Non-CNLN group, respectively (p < 0.001). Patients in the CNLN group had a shorter distant metastasis-free survival and overall survival than patients in the Non-CNLN group (p < 0.001).
The presence of CNLN in patients with PTC is a novel indicator of distant metastasis and poor survival. PTC patients accompanied with CNLN should undergo more aggressive treatment and careful follow-up.
在甲状腺乳头状癌(PTC)患者中,研究淋巴结转移(LNM)的几个特征作为复发或死亡风险的预测指标。PTC中癌结节作为LNM的一个特征尚未见报道。本研究的目的是评估淋巴结内癌结节(CNLN)在确定PTC患者远处转移风险和生存情况中的应用价值。
本回顾性观察队列研究纳入了1408例经病理证实为PTC且无初始远处转移的患者,这些患者均接受了甲状腺切除术和颈部淋巴结清扫术。根据是否存在CNLN将所有患者分为两组(CNLN组和非CNLN组)。
多因素分析显示,特殊组织学亚型的存在(OR 3.31)、CNLN(OR 7.13)和侧方LNM(OR 4.02)是远处转移的独立预测因素。CNLN组和非CNLN组患者的远处转移率分别为23.1%和2.3%(p<0.001)。此外,CNLN组和非CNLN组患者的肿瘤特异性死亡率分别为7.7%和0.6%(p<0.001)。CNLN组患者的无远处转移生存期和总生存期均短于非CNLN组患者(p<0.001)。
PTC患者中CNLN的存在是远处转移和生存不良的一个新指标。伴有CNLN的PTC患者应接受更积极的治疗和密切随访。